What is Sai Parenterals Ltd. Quarterly Revenue?

Sai Parenterals Ltd. Quarterly Revenue Sai Parenterals Sep-2026 Quarterly Revenue is Rs 57 Cr which is growth of 16.7% YoY.

What is Sai Parenterals Ltd. Quarterly Net Profit?

Sai Parenterals Ltd. Quarterly Net Profit Sai Parenterals Sep-2026 Quarterly Net Profit is Rs 6 Cr which is growth of 15.0% YoY.

What is Sai Parenterals Ltd. Annual Revenue?

Sai Parenterals Ltd. Annual Revenue Sai Parenterals Mar-2026 Annual Revenue is Rs 165 Cr which is growth of 32.4% YoY.

What is Sai Parenterals Ltd. Annual Net Profit?

Sai Parenterals Ltd. Annual Net Profit Sai Parenterals Mar-2026 Annual Net Profit is Rs 17 Cr which is growth of 63.2% YoY.

What is Sai Parenterals Ltd. Total Shareholders Fund?

Sai Parenterals Ltd. Total Shareholders Fund Sai Parenterals Mar-2026 Total Shareholders Fund is Rs 487 Cr which is growth of 433.9% YoY.

What is Sai Parenterals Ltd. Total Assets?

Sai Parenterals Ltd. Total Assets Sai Parenterals Mar-2026 Total Assets is Rs 804 Cr which is growth of 274.0% YoY.

What is Sai Parenterals Ltd. Book Value Per Share?

Sai Parenterals Ltd. Book Value Per Share Sai Parenterals Mar-2026 Book Value Per Share is 110 Rs which is growth of 221.6% YoY.

What is Sai Parenterals Ltd. ROE?

Sai Parenterals Ltd. ROE Sai Parenterals Mar-2026 ROE is 3% which is growth of 7.8% YoY.

What is Sai Parenterals Ltd. Cash From Operating Activity?

Sai Parenterals Ltd. Cash From Operating Activity Sai Parenterals Mar-2026 Cash From Operating Activity is Rs 112 Cr which is growth of 497.0% YoY.

What is Sai Parenterals Ltd. Net Cash Flow?

Sai Parenterals Ltd. Net Cash Flow Sai Parenterals Mar-2026 Net Cash Flow is Rs 409 Cr which is growth of 143171.7% YoY.

Sai Parenterals Ltd.

NSE: SAIPARENT | BSE: 544742

Slowing Down Stock

Download real time

ANDA Approvals

16.25(3.21%)

278.1K

NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The board meeting for Sai Parenterals is scheduled for today, for the purpose of Quarterly Results See details

Sai Parenterals quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Sai Parenterals quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Sai Parenterals Sep-2026 Quarterly Revenue is Rs 57 Cr which is growth of 16.7% YoY.
POSITIVE
Quarterly Net Profit Sai Parenterals Sep-2026 Quarterly Net Profit is Rs 6 Cr which is growth of 15.0% YoY.

Sai Parenterals Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Sep '26	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25
TOTAL_SR_Q Total Rev. ⌄	56.5	56.2	56.9	39.2	48.4	20.4
SR_Q Operating Rev.	52.9	52.8	56.8	38.5	47.8	19.2
OI_Q Other Income	3.6	3.4	0.1	0.8	0.6	1.2
OEXPNS_Q Operating Exp.	43.8	39.4	43.6	34.5	37.4	16.2
OEXPNS_Q Operating Exp.	43.8	39.4	43.6	34.5	37.4	16.2
OP_Q Operating Profit	9.1	13.4	13.2	4	10.4	3
OPMPCT_Q Operating Profit Margin %	17.23%	25.30%	23.29%	10.33%	21.67%	15.76%
DEP_Q Depr.	1.5	1.4	1.5	1.6	1.3	1.3
INT_Q Interest	2.5	3.6	3.4	2.1	1.5	1.8
PBT_Q Profit Before Tax	8.7	11.8	8.4	1	8.2	1.2
TAX_Q Tax	2.2	3	-1.5	0.6	2.5	0.4
NP_Q Net Profit	6.5	8.9	10	0.4	5.6	0.8
EPS_adj_Q EPS Adj. latest	1.5	2	2.3	0.1	1.3	0.2
NP_TTM Net profit TTM	25.7	24.8	16.8	-	-	-
EPS_TTM Basic EPS TTM	11.6	5.6	3.8	-	-	-
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes		Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Sai Parenterals competitor comparison and performance snapshot within industry

Sai Parenterals annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Sai Parenterals Mar-2026 Annual Revenue is Rs 165 Cr which is growth of 32.4% YoY.
POSITIVE
Annual Net Profit Sai Parenterals Mar-2026 Annual Net Profit is Rs 17 Cr which is growth of 63.2% YoY.

Sai Parenterals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	TTM	Mar '26	Mar '25	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	19.4%	208.8	165	124.6	97	90
TotalOperatingRevenues_A Operating Rev. Ann.	18.8%	201	162.3	124.3	96.8	89.2
OI_A Other Income Ann.	138.1%	7.9	2.7	0.3	0.2	0.9
OEXPNS_A Operating Exp. Ann.	18.5%	161.3	131.7	97.4	79.1	73.9
OEXPNS_A Operating Exp. Ann.	18.5%	161.3	131.7	97.4	79.1	73.9
OP_A Operating Profit Ann.	20%	39.7	30.6	26.9	17.7	15.3
OPMPCT_A OPM Ann. %	0.6%		18.53%	21.55%	18.22%	16.93%
TotalExpenses_A Total Exp. Ann. ⌄	17.7%		146.2	110.2	89.7	77.7
OtherExpenses_A Other Exp. Ann.	2.1%	13.6	13.2	13.1	12.4	6.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	17.1%	15.5	14.3	10.9	8.9	2.8
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	23%		33.3	27.2	17.9	16.1
EBIDTPCT_A EBITDA Ann. margin %	3.1%		20.20%	21.81%	18.41%	17.88%
INT_A Interest Ann.	22.4%	11.6	8.8	7.3	4.8	2.2
DEP_A Depr.	0%	6	5.8	5.5	5.8	1.6
PBT_A PBT Ann.	37.1%	29.9	18.8	14.4	7.3	12.3
TAX_A Tax Ann.	-9.5%	4.3	2	4.1	2.7	3.9
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	54%		16.8	10.3	4.6	8.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-		-	-	-	-
NP_A Net Profit Ann.	54%	25.7	16.8	10.3	4.6	8.4
NETPCT_A NPM Ann. %	29.8%		10.34%	8.27%	4.73%	9.43%
EPS_adj_A EPS Adj. latest Ann.	56%		3.8	2.3	1	1.9
result_notes Result Notes			Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

32.4%

3Y CAGR

19.4%

Net Profit Ann.

1Y CHG

63.1%

3Y CAGR

54%

Operating Exp. Ann.

1Y CHG

35.2%

3Y CAGR

18.5%

Sai Parenterals balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Sai Parenterals Mar-2026 Total Shareholders Fund is Rs 487 Cr which is growth of 433.9% YoY.
POSITIVE
Total Assets Sai Parenterals Mar-2026 Total Assets is Rs 804 Cr which is growth of 274.0% YoY.

Sai Parenterals Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '23	Mar '22
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	149.1%	487	91.2	31.5	24.3
EQCAP_A Equity Share Capital Ann.	45.3%	22.1	13.3	7.2	6.9
TotalShareCapital_A Total Share Capital Ann.	45.3%	22.1	13.3	7.2	6.9
ReservesAndSurplus_A Reserves Plus Surplus Ann.	167.5%	464.9	77.9	24.3	17.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	167.5%	464.9	77.9	24.3	17.4
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	19.5%	44.2	12.5	25.9	4.9
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-		0	0.1	0.2
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	1.5
CL_A Total Current Liabilities Ann. ⌄	52.7%	272.8	111.2	76.6	60.6
TradePayables_A Trade Payables Ann.	4.7%	25.5	32.3	22.2	16.7
OtherCurrentLiabilities_A Other Current Liabilities Ann.	214.6%	149.5	9.4	4.8	9.7
ShortTermProvisions_A ST Provisions Ann.	0.5%	6.8	9.9	6.7	3.7
TL_A Total Capital Plus Liabilities Ann.	81.7%	804	215	134	89.8
FixedAssets_A Fixed Assets Ann. ⌄	-1.7%	43.8	40.4	46.1	34.7
TangibleAssets_A Tangible Assets Ann.	-1%	42.2	39.2	43.5	33.6
IntangibleAssets_A Intangible Assets Ann.	-12.6%	0.6	0.7	0.9
CapitalWorkInProgress_A Capital Work In Progress Ann.	-11.7%	1.1	0.5	1.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	65%	217.1	84.5	48.3	36.7
NonCurrentInvestments_A Non Current Investments Ann.	-	157.7	28.4
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	1
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-			2.2	2
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	14.6	15.8
CA_A Total Current Assets Ann. ⌄	89.9%	586.9	130.4	85.7	53.2
CurrentInvestments_A Current Investments Ann.	-
TradeReceivables_A Trade Receivables Ann.	9.9%	81.2	86.5	61.2	31.6
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	500%	410.3	1.1	1.9	9.8
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	1.7	0.1	0	0.8
OtherCurrentAssets_A Other Current Assets Ann.	53.8%	34.2	16.6	9.4	7.4
TA_A Total Assets Ann.	81.7%	804	215	134	89.8
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	35.9%	14.8	14.7	5.9	8.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	2.2	2.2	2.2	2.2
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

274%

3Y CAGR

81.7%

Total Current Liabilities Ann.

1Y CHG

145.3%

3Y CAGR

52.7%

Total ShareHolders Funds Ann.

1Y CHG

434%

3Y CAGR

149.1%

Sai Parenterals ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Sai Parenterals Mar-2026 Book Value Per Share is 110 Rs which is growth of 221.6% YoY.
POSITIVE
ROE Sai Parenterals Mar-2026 ROE is 3% which is growth of 7.8% YoY.

Sai Parenterals Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '23	Mar '22
BVSH_A BVSH Ann.	35.8%	110.2	34.3	44	35.4
ROA_A RoA Ann. %	-15.3%	2.08%	4.78%	3.42%	9.36%
ROE_A ROE Ann. %	-38.2%	3.44%	11.27%	14.56%	34.62%
ROCE_A ROCE Ann. %	-37.3%	5.18%	20.90%	21.04%	49.76%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	3.6%	20.53%	21.86%	18.45%	18.05%
PBITMargin_A EBIT Ann. Margin %	10.8%	16.97%	17.44%	12.46%	16.31%
PBTMargin_A PBT Ann. Margin %	15.6%	11.56%	11.56%	7.49%	13.82%
NETPCT_A NPM Ann. %	29.8%	10.34%	8.27%	4.73%	9.43%
ASETTO_A Asset Turnover Ann. %	-30.7%	0.3	-	0.9	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	26%	2.2	1.2	1.1	0.9
QuickRatio_A Quick Ratio Ann.	23.9%	1.9	0.9	1	0.8
DividendPayoutNP_A Dividend Payout to NP Ann.	-		-	-	-
EarningRetention_A Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-
EVPerNetSales_A EV Per Net Sales Ann.	-	-	-	-	-
PBV_A Price To Book Value Adjusted	-64.3%	4.74	4.74	104.39	104.39
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-
EYield_A Earnings Yield Ann.	-
DEBT_CE_A Total Debt to Total Equity Ann.	-48.5%	0.3	0.8	2.2	1.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-69.5%

3Y CAGR

-38.2%

RoA Ann. %

1Y CHG

-56.5%

3Y CAGR

-15.3%

Current Ratio Ann.

1Y CHG

83.3%

3Y CAGR

26%

Sai Parenterals cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Sai Parenterals Mar-2026 Cash From Operating Activity is Rs 112 Cr which is growth of 497.0% YoY.
POSITIVE
Net Cash Flow Sai Parenterals Mar-2026 Net Cash Flow is Rs 409 Cr which is growth of 143171.7% YoY.

Sai Parenterals Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '23	Mar '22
CFO_A Cash from Operating Act. Ann. ⌄	-	111.5	18.7	-20.8
PBT_A PBT Ann.	37.1%	18.8	14.4	7.3	12.3
INT_A Interest Ann.	22.4%	8.8	7.3	4.8	2.2
TAX_A Tax Ann.	-9.5%	2	4.1	2.7	3.9
CFI_A Cash from Investing Act. Ann.	-	-135.6	-13.2	-17.3
CFA_A Cash from Financing Act. Ann.	143%	433.2	-5.8	30.2
NCF_A Net Cash Flow Ann. ⌄	-	409.2	-0.3	-7.9
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-51.8%	1.1	1.4	9.8
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	500%	410.3	1.1	1.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

496.3%

Cash from Financing Act. Ann.

3Y CAGR

143%

Sai Parenterals investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Sai Parenterals quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents